Fundz

Ta Announces Strategic Growth Investment In Synokem Pharmaceuticals

PRIVATEJan 18, 2023

Round Type

Venture

New DelhiManufacturing

Investors

TA Associates

Description

TA Associates (“TA”), a leading global growth private equity firm, today announced that it has completed a strategic growth investment in Synokem Pharmaceuticals Ltd. (“Synokem” or “the Company”). Synokem’s founders will continue as shareholders in the Company alongside TA.

Quick answer

Synokem Pharmaceuticals raised an undisclosed amount in a funding round, dated January 18, 2023. Investors: TA Associates. Synokem Pharmaceuticals is based in New Delhi, Delhi, India.

How much did Synokem Pharmaceuticals raise?
Synokem Pharmaceuticals raised an undisclosed amount in a funding round on January 18, 2023.
Who invested in Synokem Pharmaceuticals?
TA Associates is named as investors in this round.
What does Synokem Pharmaceuticals do?
Synokem Pharmaceuticals is one of India’s largest contract development and manufacturing organizations (CDMOs) serving marquee clients backed by strong R&D capabilities and excellent track record of execution.
Where is Synokem Pharmaceuticals based and how big is it?
Synokem Pharmaceuticals is based in New Delhi, Delhi, India.

Source: Fundz verified event record.

Who else raised in Manufacturing around the same time

Companies in the same sectors as Synokem Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Paragonix Technologies raised $24M on March 3, 2023.
  • SunOpta raised $52M on March 3, 2023.
  • Fendo Golf raised $30K (Pre-Seed) on March 3, 2023.
  • 22nd Century raised $21M (Debt Financing) on March 3, 2023.
  • PMGC Holdings Inc. raised $750K (Seed) on March 3, 2023.
  • NuevoPoly raised $100K (Pre-Seed) on March 3, 2023.

Who to call at Synokem Pharmaceuticals, and when

A new round usually means Synokem Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Synokem Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Synokem Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Synokem Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Synokem Pharmaceuticals

Location

New Delhi, Delhi, India

About

Synokem Pharmaceuticals is one of India’s largest contract development and manufacturing organizations (CDMOs) serving marquee clients backed by strong R&D capabilities and excellent track record of execution. Synokem was founded in 1983, with a vision of empowering life with quality medicines at competitive prices, and timely availability to each segment of the population. The Company’s operations began with ethical marketing before establishing its CDMO division in 2005.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Synokem Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Synokem Pharmaceuticals's next move

See what Strategic adds

Synokem Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.